DB 007-5
Alternative Names: DB-007-5Latest Information Update: 17 Mar 2025
At a glance
- Originator Derm-Biome Pharmaceuticals
- Class Anti-inflammatories; Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Atopic dermatitis